Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Xylometazoline

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 552Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    JGL’s team at the largest congress of the pharmaceutical industry
    JGL’s team at the largest congress of the pharmaceutical industry

    08 Dec 2019

    // PRESS RELEASE

    https://www.jgl.hr/en/jgls-team-at-the-largest-congress-of-the-pharmaceutical-industry

    PRESS RELEASE
    08 Dec 2019
    Share Share
    FDA approval of controversial drug for DMD raises concern and hope
    FDA approval of controversial drug for DMD raises concern and hope

    16 Nov 2016

    // NEWS MEDICAL NET

    http://www.news-medical.net/news/20161117/FDA-approval-of-controversial-drug-for-Duchenne-muscular-dystrophy-raises-concern-and-hope.aspx?

    NEWS MEDICAL NET
    16 Nov 2016
    Share Share
    GSK Healthcare shifts focus from Horlicks, banks on Sensodyne, Crocin
    GSK Healthcare shifts focus from Horlicks, banks on Sensodyne, Crocin

    05 Apr 2016

    // Ratna Bhushan ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/gsk-healthcare-shifts-focus-from-horlicks-banks-on-sensodyne-crocin-to-drive-growth-in-india/articleshow/51706616.cms

    Ratna Bhushan ECONOMIC TIMES
    05 Apr 2016
    Share Share